Mexico private health insurance premiums rise sharply

The surge is being driven by a nasty combination of higher claim frequency and higher claim severity. Insurers say elective procedures delayed during the pandemic are now showing up in the system, while an older insured pool and more chronic conditions are lifting payouts. That is feeding the industry’s version of a “death spiral,” where rising premiums drive away younger, healthier clients and leave a sicker, costlier book of business behind.

Policy changes are adding to the strain. Under Mexico’s 2026 Federal Revenue Law, the tax authority stripped insurers of a credit for the 16% value-added tax paid on medical claims, effectively raising the cost of doing business and shifting more of that burden to policyholders. Residents who file taxes in Mexico can still deduct premiums, but expatriates and others outside the local tax system get no relief.

Hospital inflation is compounding the problem. Private networks are passing along higher costs for imported medical technology, diagnostics and specialty drugs, while consolidation among operators such as Grupo Angeles and Star Medica is giving hospitals more pricing power. At the same time, bottlenecks in Mexico’s public system, including IMSS, are pushing more patients into private care, increasing demand just as the sector is becoming more expensive.

The pressure is showing up in markets that touch the healthcare trade. UnitedHealth Group, Humana competitor Cigna and hospital operator HCA Healthcare have all seen their shares move sharply this year as investors focus on pricing power, utilization trends and medical-cost inflation. In Mexico, the immediate winners are insurers and hospitals able to reprice quickly; the losers are policyholders, especially older clients and U.S. residents paid in dollars, who are also absorbing a roughly 10% peso gain against the greenback over the past year.

For investors, the key question is whether premium inflation can keep outrunning medical costs without shrinking the customer base. That will depend on claims trends, hospital pricing and whether President Claudia Sheinbaum’s planned Universal Health Service in 2027 meaningfully eases pressure on the private system by redirecting demand back into public care.